GENE ONLINE|News &
Opinion
Blog

2019-04-15| Asia-Pacific

BIOAsia-Taiwan a premier, must-attend conference for the entire Asia-Pacific region

by GeneOnline
Share To

Taiwan is a global powerhouse in technology IT and computing systems. As biotech evolves, we are creating new products that marry breakthroughs like artificial intelligence with big data derived from the human genome, that’s why Taiwan is uniquely situated to play an integral role in the future of our industry. – Jim Greenwood, President, and CEO of BIO.

In 2019, BIO Asia Taiwan will bring together cutting-edge innovators and investors from across North America, Europe and Asia to explore business opportunities with Taiwan’s emerging biotech sector. This is a premier must-attend conference for the entire Asia-pacific region.

Register Now!

Contact:
BIO Asia-Taiwan 2019 Secretariat
email: register@taiwanbio.org.tw
website: www.bioasiataiwan.com

©www.geneonline.com All rights reserved. Collaborate with us: service@geneonlineasia.com
Related Post
MedTex Summit Asia 2022: Revolutionizing Smart Healthcare with Next Generation Technologies
2022-12-09
35% of Americans May Avoid Seeking Care Due to Concerns Over Healthcare Prices
2022-10-31
Thermo Fisher Announces $59 Million Lab Expansion In Kentucky, Reveals AI Deal With Genoox
2022-10-28
LATEST
Novartis’ CDK4/6 Inhibitor Meets Phase 3 Endpoints In Breast Cancer
2023-03-28
BD and A*STAR collaborate to Advance Ultra-High Dimensional Analysis in Flow Cytometry for Immunology Research
2023-03-28
Vertex and CRISPR Collaborate Again with $330 Million Diabetes Gene Editing Deal
2023-03-28
Amway Applauded by Frost & Sullivan for Capitalizing on Innovative Competitive Strategies to Drive Differentiation in Its Home Water Treatment Solution in APAC
2023-03-28
BJ Bioscience Announces Clinical Collaboration with MSD to Evaluate BJ-001 in Combination with KEYTRUDA® (pembrolizumab)
2023-03-27
35% Of Better Therapeutics’ Staff to be Cut to Extend the Company’s Runway
2023-03-27
Pharming’s Joenja Racks Up FDA Approval For Rare Primary Immunodeficiency
2023-03-27
Scroll to Top